RxDoctor Payments Data

Jennifer Emery, DPM

Podiatrist · Bowling Green, KYNPI 1518134386

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Smith+Nephew at 35.6% of the total. That places this record below the midpoint for podiatrist clinicians in KY, where the typical reported total is $436.

$167in general payments, 2019–2025

Across 8 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$60
  • Zimmer Biomet$27
  • Rikco International, LLC$21
  • Organogenesis Inc.$20
  • Paratek Pharmaceuticals, Inc.$14
  • AbbVie$14
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$167100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew2$60
Zimmer Biomet1$27
Rikco International, LLC1$21
Organogenesis Inc.1$20
Paratek Pharmaceuticals, Inc.1$14
AbbVie1$14
Alpha Orthopedic Systems1$12

How this compares

$167 in reported general payments places this provider in the 35th percentile of 54 podiatrist providers in Kentucky.

See all podiatrist providers in Kentucky

Medicare billing

Part B allowed, 2024
$162,760
Medicare patients
498
Services billed
2,288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox188$3,302
Ammonium Lactate128$1,791
Ketoconazole43$939
Meloxicam12$774
CiclopiroxCiclopirox Olamine34$626
Gabapentin73$529
Mupirocin47$316
Doxycycline Hyclate29$158
Clindamycin Hcl22$92
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$86
Silver Sulfadiazine13$77
SsdSilver Sulfadiazine11$58
Cephalexin26$58

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →